Entering text into the input field will update the search result below

Amcor: Shares Reasonably Valued And Nearing Technical Support; Solid Yield

Dec. 18, 2022 7:42 AM ETAmcor plc (AMCR)EWD2 Comments


  • The Switzerland stock market has endured a tough 2022, but one Materials name is higher on the year.
  • I see a decent valuation given good free cash flow and a high yield.
  • On the chart, the stock could retreat further, but support is not far off.
A Close Up Shot Of An Unrecognizable Woman In A Shop Holding A Biodegradable Package Of Some Product Deciding Whether To Buy It Or Not

FreshSplash/E+ via Getty Images

Switzerland stocks have been a somewhat soft spot in the global equity market. While the Europe region features slight alpha versus the S&P 500 this year, the iShares MSCI Switzerland ETF (EWL) is down near 20%. One of the nation's

This article was written by

Freelance Financial Writer | Investments | Markets | Personal Finance | RetirementI create written content used in various formats including articles, blogs, emails, and social media for financial advisors and investment firms in a cost-efficient way. My passion is putting a narrative to financial data. Working with teams that include senior editors, investment strategists, marketing managers, data analysts, and executives, I contribute ideas to help make content relevant, accessible, and measurable. Having expertise in thematic investing, market events, client education, and compelling investment outlooks, I relate to everyday investors in a pithy way. I enjoy analyzing stock market sectors, ETFs, economic data, and broad market conditions, then producing snackable content for various audiences. Macro drivers of asset classes such as stocks, bonds, commodities, currencies, and crypto excite me. I truly enjoy communicating finance with an educational and creative style. I also believe in producing evidence-based narratives using empirical data to drive home points. Charts are one of the many tools I leverage to tell a story in a simple but engaging way. I focus on SEO and specific style guides when appropriate. I am a contributor to The Dividend Freedom Tribe.

Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Recommended For You

Comments (2)

Joe2922 profile picture
This will add value to Amcor by providing inexpensive, effective solutions to the new FDA requirement, and VRME, its new booth partner this month, much more since it's so tiny. I own VRME stock.
Sweden is not Switzerland
Disagree with this article? Submit your own. To report a factual error in this article, . Your feedback matters to us!

About AMCR

SymbolLast Price% Chg
Market Cap
Yield (TTM)
Rev Growth (YoY)
Short Interest
Prev. Close
Compare to Peers

More on AMCR

Related Stocks

SymbolLast Price% Chg
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.